Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

532
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
532
Glaucoma: Overview01:25

Glaucoma: Overview

704
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
704
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

455
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
455
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

632
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
632
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

304
Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
304
Physiological Barriers01:25

Physiological Barriers

3.8K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aprepitant for Oculoplastic Surgeries.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Emergenet: A Digital Twin of Influenza A Evolution for Vaccine Strain Forecasting and Emergence Risk Assessment.

Military medicine·2026
Same author

Dynamic partitioning shapes the <i>in vivo</i> organization of the <i>E. coli</i> RNA degradosome.

bioRxiv : the preprint server for biology·2026
Same author

Self-administered digital vaccination decision-aids in primary care: A pilot study of COVID-19 vaccination in Atlanta, GA.

Digital health·2026
Same author

Factors associated with conversion of outpatient total shoulder arthroplasty to inpatient.

Journal of shoulder and elbow surgery·2026
Same author

Balanced Restoration: Optimizing Midface Rejuvenation Using Hyaluronic Acid Fillers.

Plastic and reconstructive surgery. Global open·2026

Related Experiment Video

Updated: Sep 1, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

973

Systemic Barriers in Receiving Electronically Prescribed Glaucoma Medications.

Isdin Oke1,2, Avni Badami1, Kathryn L Kosteva1

  • 1Department of Ophthalmology, Boston Medical Center.

Journal of Glaucoma
|August 18, 2022
PubMed
Summary
This summary is machine-generated.

Over a third of electronic glaucoma prescriptions were not obtained by patients within one month. Barriers like prior authorization and insurance issues interrupt glaucoma treatment, highlighting the need for improved electronic prescribing protocols.

More Related Videos

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

321
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.6K

Related Experiment Videos

Last Updated: Sep 1, 2025

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

973
Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

321
Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
07:49

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

11.6K

Area of Science:

  • Ophthalmology
  • Health Services Research
  • Pharmacoeconomics

Background:

  • Glaucoma management necessitates consistent medication adherence for long-term disease control.
  • Socioeconomic factors significantly influence patient access to prescribed glaucoma medications.
  • Electronic prescribing (e-prescribing) aims to streamline medication delivery but may introduce new barriers.

Purpose of the Study:

  • To quantify treatment interruptions in glaucoma patients due to electronically prescribed medications.
  • To identify specific barriers hindering medication receipt after electronic prescription.
  • To propose interventions to mitigate e-prescribing-related treatment gaps.

Main Methods:

  • Cross-sectional study analyzing e-prescribing patterns at a tertiary care hospital.
  • Review of 198 glaucoma medication refill requests over a 6-week period.
  • Pharmacy contact at 1 month post-request to verify medication receipt; patient surveys for non-recipients.

Main Results:

  • 35.9% of glaucoma medications were not obtained by patients within one month of request.
  • Prior authorization was a significant barrier (OR, 0.07; 95% CI, 0.03-0.45).
  • Patient-reported barriers included insurance coverage (32.2%) and pharmacy availability (22.6%).

Conclusions:

  • A substantial portion of e-prescribed glaucoma medications are not received by patients promptly.
  • Prior authorization, insurance, and pharmacy issues are key contributors to treatment interruptions.
  • Implementing provider alerts and targeted interventions can improve medication access and prevent disease progression.